Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Want to know ways to sell products online quickly? Discover effective strategies that can help you generate sales fast.
21,381 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Quantum stocks have been front and center as grants and hype push prices higher. This guide explains why infleqtion s...
Alphabet stock looks undervalued as the tech giant rides a fresh wave of AI monetization, beating quarterly targets a...
A growing chorus of scientists pushing back warnings about microplastics challenges a decade of health scare headline...
XRP is narrowing the market-cap gap with ETH, yet analysts say overtaking remains unlikely in the near term. Here’s w...
A triple-leveraged ETF focused on semiconductors can swing wildly. This piece breaks down why the direxion daily semi...
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...
July fans risk-off mood across markets, and crypto is no exception. Bitcoin slips from recent highs as traders weigh ...
Broadcom is signaling strong momentum in AI infrastructure with a growing portfolio of custom chips and a robust back...
A once-tiny energy startup sparked a rally after finally showing a profitable revenue stream through an acquired subs...
Apple files a federal trade secret suit against OpenAI, arguing a pattern of theft to protect its hardware lead. The ...